Cargando…
Transzonular vitreous injection vs a single drop compounded topical pharmaceutical regimen after cataract surgery
PURPOSE: To compare the relative effectiveness of a Tri-Moxi-Vanc intraocular solution injected transzonularly into the vitreous with the topical formulation of Pred-Moxi-Ketor (given for the first week postoperatively) followed by Pred-Ketor (given for weeks 2–4 after surgery). PATIENTS AND METHODS...
Autores principales: | Fisher, Bret L, Potvin, Rick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957678/ https://www.ncbi.nlm.nih.gov/pubmed/27486301 http://dx.doi.org/10.2147/OPTH.S112080 |
Ejemplares similares
-
Transzonular drug delivery during cataract surgery: Is dropless cataract surgery really beneficial?
por: Pandey, Suresh K, et al.
Publicado: (2018) -
Response to: Transzonular drug delivery during cataract surgery: Is dropless cataract surgery really beneficial?
por: Maharana, Prafulla K, et al.
Publicado: (2018) -
Comparing Combination Drop Therapy to a Standard Drop Regimen After Routine Cataract Surgery
por: Solomon, Kerry D, et al.
Publicado: (2020) -
Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery
por: Guell, Jose, et al.
Publicado: (2019) -
Clinical outcomes with distance‐dominant multifocal and monofocal intraocular lenses in post‐LASIK cataract surgery planned using an intraoperative aberrometer
por: Fisher, Bret, et al.
Publicado: (2018)